Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 17/20 | 0.44 |
| ▸ | CLK2 | P49760 | 13/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 8/20 | 0.42 |
| ▸ | GSK3B | P49841 | 7/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 7/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.42 |
| ▸ | CSNK1G2 | P78368 | 6/20 | 0.42 |
| ▸ | SGK2 | Q9HBY8 | 6/20 | 0.42 |
| ▸ | DYRK3 | O43781 | 5/20 | 0.42 |
| ▸ | PRKG1 | Q13976 | 4/20 | 0.42 |
| ▸ | CSNK1G1 | Q9HCP0 | 4/20 | 0.42 |
| ▸ | CSNK1G3 | Q9Y6M4 | 4/20 | 0.42 |
| ▸ | GSK3A | P49840 | 4/20 | 0.42 |
| ▸ | HIPK2 | Q9H2X6 | 13/20 | 0.42 |
| ▸ | DAPK3 | O43293 | 12/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 12/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 12/20 | 0.42 |
| ▸ | PAK4 | O96013 | 11/20 | 0.42 |
| ▸ | PRKX | P51817 | 11/20 | 0.42 |
| ▸ | MAP4K5 | Q9Y4K4 | 11/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27788221 | 0.91 | CDC7 (0.46) | CDC7CLK2ROCK2GSK3BCLK4 | |
| SCHEMBL27810092 | 0.86 | CDC7 (0.44) | CDC7CLK2ROCK2GSK3BCLK4 | |
| SCHEMBL3669600 | 0.82 | CDC7 (0.52) | CDC7CLK2ROCK2GSK3BCLK4 | |
| SCHEMBL4293896 | 0.82 | CDC7 (0.64) | CDC7CLK2ROCK2GSK3BCLK4 | |
| Tert-Butyl Formate SCHEMBL27810094 | 0.80 | CDC7 (0.61) | CDC7CLK2ROCK2GSK3BCLK4 | |
| SCHEMBL3667784 | 0.78 | ROCK2 (0.65) | CDC7CLK2ROCK2GSK3BCLK4 | |
| SCHEMBL3670860 | 0.66 | DYRK3 (0.49) | CLK2ROCK2GSK3BCLK4MAPK1 | |
| SCHEMBL3672059 | 0.65 | ROCK2 (0.71) | CDC7CLK2ROCK2GSK3BCLK4 | |
| SCHEMBL18664515 | 0.64 | MEN1 (0.55) | CDC7KDRHDAC3HDAC4HDAC1 | |
| SCHEMBL27788231 | 0.64 | ROCK2 (0.58) | CDC7CLK2ROCK2GSK3BCLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167491-A1 | 5-HETEROARYL SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | Abbott Laboratories (US) | 2010-03-31 | — | — | EP | claimed |
| US-20090203690-A1 | 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | ABBOTT LABORATORIES (US) | 2009-08-13 | — | — | US | claimed |
| WO-2008154241-A1 | 5-HETEROARYL SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | ABBOTT LABORATORIES (US) | 2008-12-18 | — | — | WO | claimed |
| US-9163007-B2 | 5-substituted indazoles as kinase inhibitors | ABBVIE INC. (US) | 2015-10-20 | — | — | US | disclosed |
| US-20140343066-A1 | 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | AbbVie Deutschland GmbH & Co. KG (DE) | 2014-11-20 | — | — | US | disclosed |
| US-8648069-B2 | 5-substituted indazoles as kinase inhibitors | ABBVIE INC. (US) | 2014-02-11 | — | — | US | disclosed |
| EP-2167491-A1 | 5-HETEROARYL SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | Abbott Laboratories (US) | 2010-03-31 | — | — | EP | disclosed |
| US-20090203690-A1 | 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | ABBOTT LABORATORIES (US) | 2009-08-13 | — | — | US | disclosed |
| WO-2008154241-A1 | 5-HETEROARYL SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | ABBOTT LABORATORIES (US) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343066-A1 | 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | GSK3B, GSK3A, PIM3 | CDC7 8/4885CLK2 115/4885ROCK2 48/4885 |
| US-20090203690-A1 | 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS | GSK3B, GSK3A, PIM3 | CDC7 8/4885CLK2 115/4885ROCK2 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.